[HTML][HTML] Myocardial infarction with non-obstructive coronary artery disease: MI with non-obstructive coronary disease
B Lindahl, T Baron, M Albertucci, F Prati - EuroIntervention, 2021 - ncbi.nlm.nih.gov
As a result of the increased use of coronary angiography in acute myocardial infarction in
the last two decades, myocardial infarction with non-obstructive coronary arteries (MINOCA) …
the last two decades, myocardial infarction with non-obstructive coronary arteries (MINOCA) …
Causes, Angiographic Characteristics, and Management of Premature Myocardial Infarction: JACC State-of-the-Art Review
Among patients presenting with acute myocardial infarction (AMI), the proportion of young
individuals has increased in recent years. Although coronary atherosclerosis is less …
individuals has increased in recent years. Although coronary atherosclerosis is less …
Characteristics of patients with recurrent acute myocardial infarction after MINOCA
Background Myocardial infarction (MI) with non-obstructed coronary arteries (MINOCA) is an
increasingly recognized condition with challenging management. Some MINOCA patients …
increasingly recognized condition with challenging management. Some MINOCA patients …
Myocardial infarction with non-obstructive coronary arteries (MINOCA)
M Yildiz, N Ashokprabhu, A Shewale, M Pico… - Frontiers in …, 2022 - frontiersin.org
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is evident in up to
15% of all acute myocardial infarctions (AMI) and disproportionally affects females. Despite …
15% of all acute myocardial infarctions (AMI) and disproportionally affects females. Despite …
Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA …
O De Filippo, C Russo, R Manai, I Borzillo… - International Journal of …, 2022 - Elsevier
Aims To assess the impact of secondary prevention medical therapies (statins, ACE-
inhibitors/Angiotensin Receptor Blockers (ARB), beta-blockers (BB) and Dual Antiplatelet …
inhibitors/Angiotensin Receptor Blockers (ARB), beta-blockers (BB) and Dual Antiplatelet …
Coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteries: Where do we stand?
AQ Mohammed, FA Abdu, L Liu, G Yin… - European Journal of …, 2023 - Elsevier
In the past decade, scientific and clinical research has provided a translational perspective
on myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA). MINOCA is …
on myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA). MINOCA is …
Angina in 2022: Current perspectives
Angina is the main symptom of ischemic heart disease; mirroring a mismatch between
oxygen supply and demand. Epicardial coronary stenoses are only responsible for nearly …
oxygen supply and demand. Epicardial coronary stenoses are only responsible for nearly …
Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA)
Background Acute myocardial infarction with non-obstructive coronary artery disease
(MINOCA) is frequent in patients experiencing an early-onset MI, but data concerning its …
(MINOCA) is frequent in patients experiencing an early-onset MI, but data concerning its …
Coronary artery dissection and myocardial infarction with nonobstructed coronary arteries: insights from a UK nationwide autopsy-based registry—brief report
Background: Spontaneous coronary artery dissection (SCAD) and myocardial infarction with
nonobstructed coronary arteries (MINOCA) are increasingly recognized causes of acute …
nonobstructed coronary arteries (MINOCA) are increasingly recognized causes of acute …
The role of antiplatelet therapy in patients with MINOCA
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a heterogeneous
group of clinical entities characterized by the common clinical evidence of myocardial …
group of clinical entities characterized by the common clinical evidence of myocardial …